$24M for Medicago with mystery 'top-50' corporate lead for plant-based flu vaccines
29 September 2011
Nancy Faigen
Please Login to read the full article.
29 September 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- New C$50 venture fund gets Merck a first look at new technologies in Quebec
- UMN to progress first combined rotavirus/norovirus vaccine following Finnish deal
- Novavax-Cadila JV prepares to start flu and rabies vaccine studies in India
- Red tape hurt vaccine sales says Serum as it readies new intranasal trivalent flu product
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
22 May 2012
Le Plaza Hotel, Brussels, Belgium
22 May 2012
Diplomat Hotel, Prague, Czech Republic
22 May 2012
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
